Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.
BACKGROUND
Exposure to inescapable stressors increases both the rewarding properties and self-administration of cocaine through the signaling of the kappa-opioid receptor (KOR), but the effect of this signaling on other reinforcing agents remains unclear.


OBJECTIVE
The objective of this study is to test the hypothesis that signaling of the KOR mediates the forced swim stress (FSS)-induced potentiation of ethanol reward and self-administration.


METHODS
Male C57Bl/6J mice were tested in a biased ethanol-conditioned place preference (CPP) procedure, and both C57Bl/6J and prodynorphin gene-disrupted (Dyn -/-) mice were used in two-bottle free choice (TBC) assays, with or without exposure to FSS. To determine the role of the KOR in the resulting behaviors, the KOR agonist U50,488 (10 mg/kg) and antagonist nor-binaltorphimine (nor-BNI, 10 mg/kg) were administered prior to parallel testing.


RESULTS
C57Bl/6J mice exposed to repeated FSS 5 min prior to daily place conditioning with ethanol (0.8 g/kg) demonstrated a 4.4-fold potentiation of ethanol-CPP compared to unstressed mice that was prevented by nor-BNI pretreatment. Likewise, pretreatment with U50,488 90 min prior to daily ethanol place conditioning resulted in a 2.8-fold potentiation of ethanol-CPP. In the TBC assay, exposure to FSS significantly increased the consumption of 10% (v/v) ethanol by 19.3% in a nor-BNI-sensitive manner. Notably, Dyn -/- mice consumed a similar volume of ethanol as wild-type littermates and C57Bl/6J mice, but did not demonstrate significant stress-induced increases in consumption.


CONCLUSIONS
These data demonstrated a stress-induced potentiation of the rewarding effects and self-administration of ethanol mediated by KOR signaling.
Sperling
Robin E
RE
Department of Psychology, Northeastern University, Boston, MA 02115, USA.
Gomes
Stacey M
SM
Sypek
Elizabeth I
EI
Carey
Amanda N
AN
McLaughlin
Jay P
JP
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / Q000494:pharmacology; D000818:Animals; D003213:Conditioning, Psychological / Q000187:drug effects*; D004745:Enkephalins / Q000235:genetics; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D011498:Protein Precursors / Q000235:genetics; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D012201:Reward; D012646:Self Administration; D015398:Signal Transduction; D013312:Stress, Physiological
D004745:Enkephalins; D011498:Protein Precursors; D017473:Receptors, Opioid, kappa; C051844:norbinaltorphimine; D000431:Ethanol; D009271:Naltrexone; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; C033660:preproenkephalin
J Neurosci. 2009 Apr 1;29(13):4293-300
19339623
Psychopharmacology (Berl). 1995 Dec;122(4):369-73
8657835
J Pharmacol Exp Ther. 2000 Jun;293(3):1002-8
10869404
Neuropsychopharmacology. 2006 Apr;31(4):787-94
16123754
Pharmacol Biochem Behav. 1998 Jul;60(3):655-64
9678649
Alcohol. 1998 May;15(4):281-9
9590512
J Pharmacol Exp Ther. 2003 Jan;304(1):310-8
12490606
Psychopharmacology (Berl). 2004 Nov;176(2):204-13
15112031
Psychopharmacology (Berl). 1994 Apr;114(3):523-7
7855213
Behav Brain Res. 2005 Nov 7;164(2):206-13
16140402
Alcohol Clin Exp Res. 2005 May;29(5):730-8
15897716
Jpn J Pharmacol. 1992 Apr;58(4):435-42
1328733
Alcohol Clin Exp Res. 1999 Apr;23(4):683-92
10235304
Drug Alcohol Depend. 2000 Nov 1;60(3):221-47
11053757
Alcohol Clin Exp Res. 2008 Feb;32(2):240-8
18162074
Eur J Pharmacol. 1998 Jan 12;341(2-3):127-30
9543228
J Pharmacol Exp Ther. 2007 Dec;323(3):838-45
17823306
Psychopharmacology (Berl). 2000 Dec;153(1):93-102
11255932
Psychopharmacology (Berl). 2000 Sep;151(4):321-7
11026738
Addict Biol. 2006 Sep;11(3-4):289-309
16961760
Pharmacol Biochem Behav. 1977 Jan;6(1):107-15
850685
Genes Brain Behav. 2008 Apr;7(3):276-87
17711451
Psychopharmacology (Berl). 1993;112(4):503-10
7871064
Behav Brain Res. 2005 Feb 10;157(1):79-90
15617774
Alcohol Clin Exp Res. 1990 Feb;14(1):82-6
2178478
Psychopharmacology (Berl). 1990;101(2):233-9
2349365
Alcohol Clin Exp Res. 1998 May;22(3):677-84
9622450
Psychopharmacology (Berl). 2005 Nov;182(3):384-92
16001119
Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):70-5
11165373
Life Sci. 1987 Mar 30;40(13):1245-51
3561150
Alcohol Alcohol. 2002 Nov-Dec;37(6):609-12
12414556
Neuropsychopharmacology. 2006 Sep;31(9):1928-37
16292317
Psychopharmacology (Berl). 2000 Jun;150(3):317-24
10923760
Psychopharmacology (Berl). 2001 May;155(3):315-22
11432695
Psychopharmacology (Berl). 2005 Sep;181(2):327-36
15864555
Psychopharmacology (Berl). 2005 Dec;183(3):341-9
16254734
Neuropsychopharmacology. 2005 Feb;30(2):339-49
15383833
Brain Res. 2005 Sep 28;1057(1-2):72-80
16125682
Psychopharmacology (Berl). 2008 Nov;201(1):137-45
18641974
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18396-401
19841255
Physiol Behav. 2001 Jun;73(3):301-11
11438355
Alcohol. 2006 Oct;40(2):73-86
17307643
Psychopharmacology (Berl). 1997 Jan;129(2):99-111
9040115
Behav Pharmacol. 2001 Sep;12(5):335-42
11710748
Brain Res. 1990 Apr 23;514(1):22-6
2357527
Pharmacol Biochem Behav. 2004 Jul;78(3):445-58
15251253
Br J Pharmacol. 2008 May;154(2):299-315
18311194
Neuropsychopharmacology. 2008 Feb;33(3):643-52
17473837
Eur J Pharmacol. 2007 Aug 13;569(1-2):84-9
17568579
NIDA Res Monogr. 1986;75:563-66
2829003
Nature. 1998 Nov 26;396(6709):366-9
9845072
Psychopharmacology (Berl). 1992;107(2-3):385-93
1352057
Alcohol. 2009 Aug;43(5):359-65
19671462
Alcohol Clin Exp Res. 2006 May;30(5):783-90
16634846
Alcohol Clin Exp Res. 2006 Apr;30(4):592-7
16573576
Behav Brain Res. 2001 May;120(2):137-46
11182162
Alcohol Clin Exp Res. 1997 Dec;21(9):1661-6
9438527
Eur J Pharmacol. 1999 Feb 26;368(1):9-16
10096764
Neurosci Biobehav Rev. 1981 Summer;5(2):209-29
6115346
J Neurosci. 2003 Jul 2;23(13):5674-83
12843270
Pharmacol Ther. 2007 Nov;116(2):306-21
17868902
Neurosci Biobehav Rev. 2004 Jan;27(8):739-49
15019424
J Neurochem. 2004 Sep;90(5):1258-68
15312181